Skip to main content
Erschienen in: Cancer Causes & Control 7/2010

01.07.2010 | Brief report

Poverty and childhood cancer incidence in the United States

verfasst von: I-Jen Pan, Julie L. Daniels, Kangmin Zhu

Erschienen in: Cancer Causes & Control | Ausgabe 7/2010

Einloggen, um Zugang zu erhalten

Abstract

This study examined socioeconomic differentials in cancer incidence rates during 2000–2005 among children aged 0–19 in the United States. The data on childhood cancers, which were classified by the International Classification of Childhood Cancer, Third Edition (ICCC-3), were obtained from the Surveillance, Epidemiology, and End Results program. The socioeconomic status of residential area at diagnosis was estimated by county-level poverty rate in Census 2000, i.e., percentage of persons in the county living below the national poverty thresholds. Counties were categorized as low-, medium-, and high-poverty areas when the poverty rates were <10, 10–19.99, and 20% or higher, respectively. The results showed that medium- and high-poverty counties had lower age-adjusted incidence rates than low-poverty counties for total childhood cancers combined, central nervous system neoplasms (ICCC group III), neuroblastoma (group IV), renal tumors (group VI), and other malignant epithelial neoplasms and malignant melanomas (group XI). When the data were stratified by race, these associations were observed among whites, but not blacks. For leukemia (group I), poor counties had higher incidence rates than affluent counties for whites, but lower rates for blacks. This ecologic study provides perspective on area socioeconomic variations in childhood cancer incidence that warrants further research.
Literatur
1.
Zurück zum Zitat Singh GK, Miller BA, Hankey BF, Edwards BK (2003) Area socioeconomic variations in US cancer incidence, mortality, stage, treatment, and survival, 1975–1999. National Cancer Institute, Bethesda. Report No.: NIH Publication No. 03-5417 Singh GK, Miller BA, Hankey BF, Edwards BK (2003) Area socioeconomic variations in US cancer incidence, mortality, stage, treatment, and survival, 1975–1999. National Cancer Institute, Bethesda. Report No.: NIH Publication No. 03-5417
2.
Zurück zum Zitat Reynolds T (2003) Report examines association between cancer and socioeconomic status. J Natl Cancer Inst 95(19):1431–1433PubMed Reynolds T (2003) Report examines association between cancer and socioeconomic status. J Natl Cancer Inst 95(19):1431–1433PubMed
3.
Zurück zum Zitat Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ et al (2008) SEER cancer statistics review, 1975–2005. National Cancer Institute, Bethesda Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ et al (2008) SEER cancer statistics review, 1975–2005. National Cancer Institute, Bethesda
4.
Zurück zum Zitat Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P (2005) International classification of childhood cancer, third edition. Cancer 103(7):1457–1467CrossRefPubMed Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P (2005) International classification of childhood cancer, third edition. Cancer 103(7):1457–1467CrossRefPubMed
5.
Zurück zum Zitat Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? The Public Health Disparities Geocoding Project. Am J Epidemiol 156(5):471–482CrossRefPubMed Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? The Public Health Disparities Geocoding Project. Am J Epidemiol 156(5):471–482CrossRefPubMed
6.
Zurück zum Zitat Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV (2003) Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of area-based socioeconomic measures—the public health disparities geocoding project. Am J Public Health 93(10):1655–1671CrossRefPubMed Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV (2003) Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of area-based socioeconomic measures—the public health disparities geocoding project. Am J Public Health 93(10):1655–1671CrossRefPubMed
7.
Zurück zum Zitat Poole C, Greenland S, Luetters C, Kelsey JL, Mezei G (2006) Socioeconomic status and childhood leukaemia: a review. Int J Epidemiol 35(2):370–384CrossRefPubMed Poole C, Greenland S, Luetters C, Kelsey JL, Mezei G (2006) Socioeconomic status and childhood leukaemia: a review. Int J Epidemiol 35(2):370–384CrossRefPubMed
8.
Zurück zum Zitat Adam M, Rebholz CE, Egger M, Zwahlen M, Kuehni CE (2008) Childhood leukaemia and socioeconomic status: what is the evidence? Radiat Prot Dosimetry 132(2):246–254CrossRefPubMed Adam M, Rebholz CE, Egger M, Zwahlen M, Kuehni CE (2008) Childhood leukaemia and socioeconomic status: what is the evidence? Radiat Prot Dosimetry 132(2):246–254CrossRefPubMed
9.
Zurück zum Zitat Smith A, Roman E, Simpson J, Ansell P, Fear NT, Eden T (2006) Childhood leukaemia and socioeconomic status: fact or artefact? A report from the United Kingdom childhood cancer study (UKCCS). Int J Epidemiol 35(6):1504–1513CrossRefPubMed Smith A, Roman E, Simpson J, Ansell P, Fear NT, Eden T (2006) Childhood leukaemia and socioeconomic status: fact or artefact? A report from the United Kingdom childhood cancer study (UKCCS). Int J Epidemiol 35(6):1504–1513CrossRefPubMed
10.
Zurück zum Zitat Mezei G, Borugian MJ, Spinelli JJ, Wilkins R, Abanto Z, McBride ML (2006) Socioeconomic status and childhood solid tumor and lymphoma incidence in Canada. Am J Epidemiol 164(2):170–175CrossRefPubMed Mezei G, Borugian MJ, Spinelli JJ, Wilkins R, Abanto Z, McBride ML (2006) Socioeconomic status and childhood solid tumor and lymphoma incidence in Canada. Am J Epidemiol 164(2):170–175CrossRefPubMed
11.
Zurück zum Zitat Borugian MJ, Spinelli JJ, Mezei G, Wilkins R, Abanto Z, McBride ML (2005) Childhood leukemia and socioeconomic status in Canada. Epidemiology 16(4):526–531CrossRefPubMed Borugian MJ, Spinelli JJ, Mezei G, Wilkins R, Abanto Z, McBride ML (2005) Childhood leukemia and socioeconomic status in Canada. Epidemiology 16(4):526–531CrossRefPubMed
12.
Zurück zum Zitat Bandi P, Dranger E, Hampton JM, Trentham-Dietz A (2006) Trends in childhood cancer incidence in Wisconsin, 1980–1999. WMJ 105(7):30–37PubMed Bandi P, Dranger E, Hampton JM, Trentham-Dietz A (2006) Trends in childhood cancer incidence in Wisconsin, 1980–1999. WMJ 105(7):30–37PubMed
13.
Zurück zum Zitat McNally RJ, Alston RD, Cairns DP, Eden OB, Kelsey AM, Birch JM (2003) Geographical and ecological analyses of childhood Wilms’ tumours and soft-tissue sarcomas in North West England. Eur J Cancer 39(11):1586–1593CrossRefPubMed McNally RJ, Alston RD, Cairns DP, Eden OB, Kelsey AM, Birch JM (2003) Geographical and ecological analyses of childhood Wilms’ tumours and soft-tissue sarcomas in North West England. Eur J Cancer 39(11):1586–1593CrossRefPubMed
14.
Zurück zum Zitat McKinney PA, Ironside JW, Harkness EF, Arango JC, Doyle D, Black RJ (1994) Registration quality and descriptive epidemiology of childhood brain tumours in Scotland 1975–90. Br J Cancer 70(5):973–979PubMed McKinney PA, Ironside JW, Harkness EF, Arango JC, Doyle D, Black RJ (1994) Registration quality and descriptive epidemiology of childhood brain tumours in Scotland 1975–90. Br J Cancer 70(5):973–979PubMed
15.
Zurück zum Zitat Ries LAG, Smith MA, Gurney JG, Linet M, Tamara T, Young JL et al (1999) Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. National Cancer Institute, SEER Program, Bethesda Ries LAG, Smith MA, Gurney JG, Linet M, Tamara T, Young JL et al (1999) Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. National Cancer Institute, SEER Program, Bethesda
16.
Zurück zum Zitat Little J (1999) Epidemiology of childhood cancer. International Agency for Research on Cancer, Lyon/Distributed by Oxford University Press, Oxford Little J (1999) Epidemiology of childhood cancer. International Agency for Research on Cancer, Lyon/Distributed by Oxford University Press, Oxford
17.
Zurück zum Zitat Linet MS, Wacholder S, Zahm SH (2003) Interpreting epidemiologic research: lessons from studies of childhood cancer. Pediatrics 112(1 Pt 2):218–232PubMed Linet MS, Wacholder S, Zahm SH (2003) Interpreting epidemiologic research: lessons from studies of childhood cancer. Pediatrics 112(1 Pt 2):218–232PubMed
18.
Zurück zum Zitat Brain JD, Kavet R, McCormick DL, Poole C, Silverman LB, Smith TJ et al (2003) Childhood leukemia: electric and magnetic fields as possible risk factors. Environ Health Perspect 111(7):962–970PubMed Brain JD, Kavet R, McCormick DL, Poole C, Silverman LB, Smith TJ et al (2003) Childhood leukemia: electric and magnetic fields as possible risk factors. Environ Health Perspect 111(7):962–970PubMed
19.
Zurück zum Zitat Hjalgrim LL, Westergaard T, Rostgaard K, Schmiegelow K, Melbye M, Hjalgrim H et al (2003) Birth weight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiologic studies. Am J Epidemiol 158(8):724–735CrossRefPubMed Hjalgrim LL, Westergaard T, Rostgaard K, Schmiegelow K, Melbye M, Hjalgrim H et al (2003) Birth weight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiologic studies. Am J Epidemiol 158(8):724–735CrossRefPubMed
20.
Zurück zum Zitat Raaschou-Nielsen O, Reynolds P (2006) Air pollution and childhood cancer: a review of the epidemiological literature. Int J Cancer 118(12):2920–2929CrossRefPubMed Raaschou-Nielsen O, Reynolds P (2006) Air pollution and childhood cancer: a review of the epidemiological literature. Int J Cancer 118(12):2920–2929CrossRefPubMed
21.
Zurück zum Zitat Neelanjana M, Sabaratnam A (2008) Malignant conditions in children born after assisted reproductive technology. Obstet Gynecol Surv 63(10):669–676CrossRefPubMed Neelanjana M, Sabaratnam A (2008) Malignant conditions in children born after assisted reproductive technology. Obstet Gynecol Surv 63(10):669–676CrossRefPubMed
22.
Zurück zum Zitat Caughey RW, Michels KB (2009) Birth weight and childhood leukemia: a meta-analysis and review of the current evidence. Int J Cancer 124(11):2658–2670CrossRefPubMed Caughey RW, Michels KB (2009) Birth weight and childhood leukemia: a meta-analysis and review of the current evidence. Int J Cancer 124(11):2658–2670CrossRefPubMed
23.
Zurück zum Zitat Singh GK, Kogan MD (2007) Widening socioeconomic disparities in US childhood mortality, 1969–2000. Am J Public Health 97(9):1658–1665CrossRefPubMed Singh GK, Kogan MD (2007) Widening socioeconomic disparities in US childhood mortality, 1969–2000. Am J Public Health 97(9):1658–1665CrossRefPubMed
24.
Zurück zum Zitat Singh GK, Kogan MD (2007) Persistent socioeconomic disparities in infant, neonatal, and postneonatal mortality rates in the United States, 1969–2001. Pediatrics 119(4):e928–e939CrossRefPubMed Singh GK, Kogan MD (2007) Persistent socioeconomic disparities in infant, neonatal, and postneonatal mortality rates in the United States, 1969–2001. Pediatrics 119(4):e928–e939CrossRefPubMed
Metadaten
Titel
Poverty and childhood cancer incidence in the United States
verfasst von
I-Jen Pan
Julie L. Daniels
Kangmin Zhu
Publikationsdatum
01.07.2010
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 7/2010
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9528-3

Weitere Artikel der Ausgabe 7/2010

Cancer Causes & Control 7/2010 Zur Ausgabe

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.